NVCR News and Press, NovoCure Limited From 08/23/19

Race car driver Mikaela Ahlin-Kottulinsky and her helmet (photo via Forbes ). Bulletproof Investing: Week 91 Performance Each week, since the beginning of June 2017, I have presented at least two hedged portfolios created by Portfolio Armor to my Bulletproof Investing subscribers. This ...

Image via Retail Detail . Alibaba And The Hedged Portfolio Method One of the great new tools Seeking Alpha has added to its Essential offering is its Quant Ratings, which take into account value, growth, profitability, momentum, and EPS revisions. There's an interesting contrast betw...

This is a special contribution article by Prof. Grant Henning based on his published research on the BLM technical theory . The model, his trailing stop-loss approach, and comments are expressly based on his own proprietary methodology and forecasts in the references below. Winning Bounc...

The following slide deck was published by NovoCure Limited in conjunction with this Read more ...

This is a special contribution article by Prof. Grant Henning based on his published research on the BLM technical theory . The model, his trailing stop-loss approach, and comments are expressly based on his own proprietary methodology and forecasts in the references below. Winning Bounc...

SHANGHAI, China and ST. HELIER, Jersey, Aug. 12, 2019 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB), a Shanghai-based innovative commercial stage biopharmaceutical company, and Novocure (NASDAQ: NVCR), a global oncology company with a proprietary platform technology called Tumor Treati...

This stock idea is totally out of range for TheMoneyMadam except for one metric and that is call option potential; that potential allows you to generate income on a non-dividend stock. If you believe in your pick, you can concentrate on reaping gains from a growth stock while you work the call...

Novocure (NASDAQ: NVCR) announced today that it will participate in three upcoming investor conferences. Pritesh Shah, Novocure’s Chief Commercial Officer, will participate in the Wedbush PacGrow Healthcare Conference on August 14, 2019, in New York City. Mr. Shah’s present...

This is a special contribution article by Prof. Grant Henning based on his published research on the BLM technical theory . The model, his trailing stop-loss approach, and comments are expressly based on his own proprietary methodology and forecasts in the references below. Winning Bounc...

NovoCure ( NVCR ) reported strong Q2 results, beating both revenue and EPS estimates. Part of the beat was a non-recurring $5 million revenue benefit, but Optune has delivered strong sequential and Y/Y growth even if the one-time benefit is excluded. NovoCure saw good news on all fronts in...